SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-194372
Filing Date
2021-06-21
Accepted
2021-06-21 09:57:01
Documents
12
Period of Report
2021-06-18
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d167334d8k.htm   iXBRL 8-K 25784
  Complete submission text file 0001193125-21-194372.txt   148573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20210618.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210618_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210618_pre.xml EX-101.PRE 11410
5 EXTRACTED XBRL INSTANCE DOCUMENT d167334d8k_htm.xml XML 3370
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 211027878
SIC: 2834 Pharmaceutical Preparations